课程列表
查看专区 查看公开课
所有分类：
分类:
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine
2683 0 19.9元
Healing of rotator cuff tendons using botulinum toxin A and immobilization in a rat model
Healing of rotator cuff tendons using botulinum toxin A and immobilization in a rat model
2877 0 19.9元
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic
2370 0 19.9元
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of
2374 0 19.9元
Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine
2462 0 19.9元
OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and
OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and
2752 0 19.9元
Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from
Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from
3018 0 19.9元
Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’
Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’
2694 0 19.9元
Pharmacological differences and clinical implications of various botulinum toxin preparations
Pharmacological differences and clinical implications of various botulinum toxin preparations
2927 0 19.9元
Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder
Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder
2846 0 19.9元
A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25
A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25
2380 0 19.9元
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review
2332 0 19.9元
Cellular and Matrix Response of the Mandibular Condylar Cartilage to Botulinum Toxin
Cellular and Matrix Response of the Mandibular Condylar Cartilage to Botulinum Toxin
2661 0 19.9元
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in
2360 0 19.9元
Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine
Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine
1859 0 19.9元
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic
Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic
2306 0 19.9元
Comparison of neurotoxic potency between a novel chinbotulinumtoxina with onabotulinumtoxina,
Comparison of neurotoxic potency between a novel chinbotulinumtoxina with onabotulinumtoxina,
2532 0 19.9元
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX) for the Management of Urinary Incontinence
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX) for the Management of Urinary Incontinence
3498 0 19.9元
Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
2597 0 19.9元
Content of Botulinum Neurotoxin in Botox® / Vistabel®, Dysport® /Azzalure®, and Xeomin® / Bocouture®
Content of Botulinum Neurotoxin in Botox® / Vistabel®, Dysport® /Azzalure®, and Xeomin® / Bocouture®
2977 0 19.9元